Rightway, an alternative pharmacy benefit manager (PBM), is trending upward and best positioned to challenge the "Big 3" ...

While Stelara is used in fewer indications than Humira, it commands a large market share in its therapeutic areas, most ...

Omada Health (OMDA) is a strong buy. Backed by 29 studies, key partnerships with Cigna and CVS drive growth, credibility, and ...

Novo Nordisk A/S (NYSE: NVO) is one of the high-margin pharma stocks to buy now. Berenberg has reaffirmed its Hold rating on ...

CVS wins a major CalPERS deal as Caremark replaces OptumRx, backed by $250M in performance guarantees and drug cost controls.

Meta shareholders abruptly settled an $8 billion lawsuit accusing Mark Zuckerberg and other executives of oversight failures ...

Over half of large US employers plan to cut health benefits in 2026 as rising costs of weight-loss drugs like Wegovy drive up ...

More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from weight-loss and ...

A landmark trial on board oversight ends abruptly as Meta leaders settle multibillion-dollar lawsuit over privacy lapses.

Mark Zuckerberg and Meta's current and former executives have settled an $8 billion lawsuit over privacy violations, avoiding ...

CVS Health has secured a major healthcare deal, winning a multi-year pharmacy benefits contract with CalPERS, outbidding rival UnitedHealth. The deal marks a significant win for CVS's Caremark unit ...

Litigation over state power to regulate pharmacy benefit managers is far from over, even after the US Supreme Court bolstered ...